Literature DB >> 8826966

Skeletal muscle content of membrane glycoprotein PC-1 in obesity. Relationship to muscle glucose transport.

J F Youngren1, B A Maddux, S Sasson, P Sbraccia, E B Tapscott, M S Swanson, G L Dohm, I D Goldfine.   

Abstract

Membrane glycoprotein PC-1, an inhibitor of insulin signaling, produces insulin resistance when overexpressed in cells transfected with PC-1 cDNA. In the present study, we determined whether PC-1 plays a role in the insulin resistance of skeletal muscle in obesity. Rectus abdominus muscle biopsies were taken from patients undergoing elective surgery. Subjects included both NIDDM patients (n = 14) and nondiabetic patients (n = 34) across a wide range of BMI values (19.5-90.1). Insulin-stimulated glucose transport was measured in incubated muscle strips, and PC-1 content, enzymatic activity, and insulin receptor content were measured in solubilized muscle extracts. Increasing BMI correlated with both an increase in the content of PC-1 in muscle (r = 0.55, P < 0.001) and a decrease in insulin stimulation of muscle glucose transport (r = -0.58, P = 0.008). NIDDM had no effect on either PC-1 content or glucose transport for any given level of obesity. Insulin stimulation of muscle glucose transport was negatively related to muscle PC-1 content (r = -0.68, P = 0.001) and positively related to insulin receptor content (r = 0.60, P = 0.005). Multivariate analysis indicated that both skeletal muscle PC-1 content and insulin receptor content, but not BMI, were independent predictors of insulin-stimulated glucose transport. Muscle PC-1 content accounted for 42% and insulin receptor content for 17% of the variance in glucose transport values. These studies raise the possibility that increased expression of PC-1 and a decreased insulin receptor content in skeletal muscle may be involved in the insulin resistance of obesity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8826966     DOI: 10.2337/diab.45.10.1324

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  9 in total

Review 1.  Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance.

Authors:  A Virkamäki; K Ueki; C R Kahn
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

2.  Changes in glycoprotein components in streptozotocin--nicotinamide induced type 2 diabetes: influence of tetrahydrocurcumin from Curcuma longa.

Authors:  Leelavinothan Pari; Pidaran Murugan
Journal:  Plant Foods Hum Nutr       Date:  2007-01-17       Impact factor: 3.921

3.  Hepatic ENPP1 expression is induced in diabetic rabbits.

Authors:  Philipp Eller; Kathrin Hochegger; Andreas Wehinger; Ivan Tancevski; Wilfried Schgoer; Andreas Ritsch; Josef R Patsch
Journal:  Mamm Genome       Date:  2006-08-04       Impact factor: 2.957

Review 4.  Membrane glycoprotein PC-1 and insulin resistance.

Authors:  I D Goldfine; B A Maddux; J F Youngren; L Frittitta; V Trischitta; G L Dohm
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

5.  Increased PC-1 phosphodiesterase activity and inhibition of glucose uptake in adipocytes of type 2 diabetic rats.

Authors:  Karlene Barrett; Donovan McGrowder; Paul Brown; Dalip Ragoobirsingh
Journal:  Mol Cell Biochem       Date:  2006-09-04       Impact factor: 3.396

6.  ENPP1 K121Q polymorphism is not related to type 2 diabetes mellitus, features of metabolic syndrome, and diabetic cardiovascular complications in a Chinese population.

Authors:  Miao-Pei Chen; Fu-Mei Chung; Dao-Ming Chang; Jack C-R Tsai; Han-Fen Huang; Shyi-Jang Shin; Yau-Jiunn Lee
Journal:  Rev Diabet Stud       Date:  2006-05-10

Review 7.  The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities.

Authors:  Ira D Goldfine; Betty A Maddux; Jack F Youngren; Gerald Reaven; Domenico Accili; Vincenzo Trischitta; Riccardo Vigneri; Lucia Frittitta
Journal:  Endocr Rev       Date:  2008-01-16       Impact factor: 19.871

Review 8.  Association between the ENPP1 K121Q polymorphism and risk of diabetic kidney disease: a systematic review and meta-analysis.

Authors:  Denise Alves Sortica; Marjorie Piucco Buffon; Bianca Marmontel Souza; Bruna Bellicanta Nicoletto; Andressa Santer; Tais Silveira Assmann; Daisy Crispim; Luis Henrique Canani
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

Review 9.  Insulin resistance: a proinflammatory state mediated by lipid-induced signaling dysfunction and involved in atherosclerotic plaque instability.

Authors:  Fabrizio Montecucco; Sabine Steffens; François Mach
Journal:  Mediators Inflamm       Date:  2008       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.